Immune response profiles in human skin

British Journal of Dermatology

Volumn 157, Issue SUPPL. 2, 2007, Pages 1-7

  Meyer, T ^a   Stockfleth, E ^b   Christophers, E ^c  

^a Inst Immunol   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Adaptive immunity; Epithelial defense; Innate immunity; TH17 cell; Toll like receptor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL SPECIFICITY; CYTOKINE PRODUCTION; DEFENSE MECHANISM; DENDRITIC CELL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 36549027785     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08264.x     Document Type: Article

References (72)

1. Christophers E. Cellular architecture of the stratum corneum. J Invest Dermatol 1971 56: 165 9.
2. Elias PM. Stratum corneum architecture, metabolic activity and interactivity with subjacent cell layers. Exp Dermatol 1996 5: 191 201.
3. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006 63: 469 86.
4. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20: 197 216.
5. Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993 14: 75 8.
6. Boman HG. Antimicrobial peptides: basic facts and emerging concepts. J Intern Med 2003 254: 197 215.
7. Lehrer RI, Ganz T. Antimicrobial peptides in mammalian and insect host defense. Curr Opin Immunol 1999 11: 23 7.
8. Ogawa H, Miyazaki H, Kimura M. Isolation and characterization of human skin lysozyme. J Invest Dermatol 1971 57: 111 16.
9. Harder J, Schröder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005 77: 476 86.
10. Gläser R, Harder J, Lange H et al. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005 6:57 64.
11. Sörensen OE, Thapa DR, Rosenthal A et al. Differential regulation of beta defensin expression in human skin by microbial stimuli. J Immunol 2005 174:4870 9.
12. Nagy I, Pivarcsi A, Koreck A et al. Distinct strains of Propionibacterium acnes induce selective human beta-defensin 2 and interleukin 8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol 2005 124:931 8.
13. Yang D, Chertov O, Bykovskaia SN et al. Beta-defensis: liniking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999 286:525 8.
14. Bals R, Wilson JM. Cathelicidins - a family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003 60:711 20.
15. Medzhitov R, Janeway CA. Innate immunity. N Engl J Med 2000 343:338 44.
16. Raz E. Organ-specific regulation of innate immunity. Nat Immunol 2007 8:3 4.
17. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001 2:675 80.
18. Barton GM, Medzhitov R. Toll-like receptors and their ligands. Curr Top Microbiol Immunol 2002 270:81 92.
19. O'Neill L. How Toll-like receptors signal: what we know and what we don′t know. Curr Opin Immunol 2006 18:3 9.
20. Uematsu S, Sato S, Yamamoto M et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR) 7- and TLR 9-mediated interferon-(alpha) induction. J Exp Med 2005 201:915 23.
21. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002 168:554 61.
22. Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood momonuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002 168:4531 7.
23. Gorden KB, Gorski KS, Gibson SJ et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005 174:1259 68.
24. Jarrossay D, Napolitani G, Colonna M et al. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 2001 31:3388 93.
25. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different Toll-like receptorsand respond to different microbial antigens. J Exp Med 2001 194:863 9.
26. Hasan U, Chaffois C, Gaillard C et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005 174:2942 50.
27. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003 85:85 95.
28. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002 3:196 200.
29. Gibson SJ, Lindh JM, Riter TR et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol 2002 218:74 86.
30. Lebre MC, van der Aar AMG, van Baarsen L et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007 127:331 41.
31. Köllisch G, Kalali BN, Voelcker V et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005 114:531 41.
32. Baker BS, Ovigne JM, Powles AV et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2, and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 2003 148:670 9.
33. Song PI, Park YM, Abraham T et al. Human keratinocytes express functional CD14 and Toll-like receptor 4. J Invest Dermatol 2002 119:424 34.
34. Flacher V, Bouschbacher M, Verronese E et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 2006 177:7959 67.
35. Waibler Z, Kalinke U, Will J et al. TLR-ligand stimulated interleukin 23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells. Mol Immunol 2007 44:1483 9.
36. Palamara F, Meindl S, Holcmann M et al. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J Immunol 2004 173:3051 61.
37. Nestle FO, Conrad C, Tun-Kyi A. et al. Plasmacytoid predendritic cells (PDC) initiate psoriasis through interferon-α production. J Exp Med 2005 202:135 43.
38. Gilliet M, Conrad C, Geiges M et al. Psoriasis triggered by Toll-like recptor agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004 140:1490 5.
39. McKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL17 immune pathway. Trends Immunol 2006 27:17 23.
40. Blauvelt A. New concepts in the pathogenesis and treatment of psoriasis: key roles for Il-17 and TGFb. Exp Rev Dermatol 2007 2:69 78.
41. Murphy KM, Reiner SL. The lineage decision of helper T cells. Nat Rev Immunol 2002 2:933 44.
42. Kolls JK, Linden A. Interleukin 17 family members and inflammation. Immunity 2004 21:467 76.
43. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002 14:129 35.
44. Nagalakshmi ML, Rascle A, Zurawski S et al. Interleukin 22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol 2004 4:679 91.
45. Chung Y, Yang X, Chang SH et al. Expression and regulation of IL-22 in the IL-17 producing T lymphocytes. Cell Res 2006 16:902 7.
46. Zheng Y, Danilenko DM, Valdez P et al. Interleukin 22, a Th17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007 445:648 51.
47. Sa SM, Valdez PA, Wu J et al. The effects of IL-20 subfamily cytokines in reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenetic adaptive immunity in psoriasis. J Immunol 2007 178:2229 40.
48. Wolk K, Kunz S, Witte E et al. IL-22 increaes the innate immunity of tissues. Immunity 2004 21:241 54.
49. Liang SC, Tan XY, Luxenberg DP et al. Interleukin (IL)-22 and Il-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006 203:2271 9.
50. Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol 2006 31:140 1.
51. Fanti PA, Dika E, Vaccari S et al. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006 45:1464 5.
52. Lee E, Trepicchio WL, Oestreicher JL et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004 199:125 30.
53. Toichi E, Torres G, McCormick TS et al. An anti-IL12-p40 antibody down-regulates type 1 cytokines, chemokines, and IL12/Il23 in psoriasis. J Immunol 2006 177:4917 26.
54. Schröder JM, Christophers E. Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986 87:53 8.
55. Takematsu H, Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL8) in psoriatic lesional skin. Arch Dermatol 1993 129:74 80.
56. Beutler B. Innate immunity: an overview. Mol Immunol 2004 40:845 59.
57. Cain SA, Monk PN. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg. J Biol Chem 2002 277:7165 9.
58. Gutzmer R, Köther B, Zwirner J et al. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J Invest Dermatol 2006 126:2422 9.
59. Larregina AT, Falo LD. Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 2005 124:1 12.
60. Larregina AT, Falo LD. Dendritic cells in the context of skin immunity. In:Dendritic Cell Biology and Clinical Applications Lotze M, Thomas AW eds AP London UK:Academic Press, 2001 chapter 23:301 14.
61. Kovacsovics-Bankowski M, Rock K. A phagosome to cytosol pathwayfor exogenous antigens presented on MHC class I molecules. Science 1995 267:243 6.
62. Hunger RE, Sieling PA, Ochoa MT. Langerhans cells utilize CD1a and langerin to efficiently present non-peptide antigens to T cells. J Clin Invest 2004 113:701 8.
63. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004 22:817 90.
64. Steinmann RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21:685 711.
65. Nickoloff BJ. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J Dermatol Sci 2002 29:159 65.
66. Morelli AE, Hackstein H, Thomson AW. Potential tolerogenic dendritic cells for transplantation. Semin Immunol 2001 13:323 35.
67. Picker LJ, Michie SA, Rott LS, Butcher ECA. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990 138:1053 68.
68. Pitzalis C, Cauli A, Pipitone N et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to skin but not to the joint in psoriatic arthritis. Arthritis Rheum 1996 39:137 45.
69. Biedermann T, Schwarzler C, Lametschwandtner G et al. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 2002 32:3171 80.
70. Hudak S, Hagen M, Liu Y et al. Immune surveillance and effector functions of CCR10+ skin homing T cells. J Immunol 2002 169:1189 96.
71. Kikly K, Liu L, Na S, Sedgwick JD. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006 18:670 5.
72. Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 2003 171:6323 7.